Francis Hung Nguyen

Title: Innovations by Francis Hung Nguyen

Introduction

Francis Hung Nguyen is a notable inventor based in Daly City, CA (US). He has made significant contributions to the field of biomedical research, particularly in the development of vascular endothelial growth factor (VEGF) variants. With a total of 5 patents to his name, Nguyen's work has the potential to impact therapeutic approaches in various medical conditions.

Latest Patents

Nguyen's latest patents focus on the preparation of VEGF variants, which are designed to enhance binding characteristics to specific receptor domains. One of his inventions, titled "Variants of vascular endothelial cell growth factor, their uses, and processes for their production," involves the modification of binding regions within the VEGF molecule. This innovation allows for selective changes that can interrupt binding to the KDR and FLT-1 receptors, ultimately modifying the biological characteristics of the VEGF molecule. Another patent with a similar focus also emphasizes the preparation of VEGF variants with selective binding properties.

Career Highlights

Francis Hung Nguyen is currently associated with Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Genentech has positioned him at the forefront of research in vascular biology and therapeutic applications.

Collaborations

Nguyen has collaborated with esteemed colleagues such as Bruce A Keyt and Napoleone Ferrara, further enhancing the impact of his research through shared expertise and insights.

Conclusion

Francis Hung Nguyen's contributions to the field of vascular biology through his innovative patents demonstrate his commitment to advancing medical science. His work continues to pave the way for new therapeutic strategies that could benefit patients worldwide.